机构：[1]Guangdong Provincial Hospital of Chinese Medicine, GuangZhou, China,广东省中医院[2]Global Health – Health Systems and Policy: Medicines, focusing antibiotics, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden,[3]School of Health and Biomedical Science, Royal Melbourne Institute of Technology, Melbourne, Australia,[4]Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
第一作者机构：[1]Guangdong Provincial Hospital of Chinese Medicine, GuangZhou, China,[2]Global Health – Health Systems and Policy: Medicines, focusing antibiotics, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden,
推荐引用方式(GB/T 7714)：
Su G.,Wu Y.,Yang L.,et al.TRIPTERYGIUM FOR HENOCHSCHONLEIN PURPURA NEPHRITIS: A CASE STUDY OF EVIDENCE-BASED DECISION MAKING OF CHINESE MEDICINE[J].NEPHROLOGY.2016,21:265-265.
APA：
Su, G.,Wu, Y.,Yang, L.,Zhang, L.,Carrero, Jesus J....&Zou, C..(2016).TRIPTERYGIUM FOR HENOCHSCHONLEIN PURPURA NEPHRITIS: A CASE STUDY OF EVIDENCE-BASED DECISION MAKING OF CHINESE MEDICINE.NEPHROLOGY,21,
MLA：
Su, G.,et al."TRIPTERYGIUM FOR HENOCHSCHONLEIN PURPURA NEPHRITIS: A CASE STUDY OF EVIDENCE-BASED DECISION MAKING OF CHINESE MEDICINE".NEPHROLOGY 21.(2016):265-265
